Suppr超能文献

桡动脉与隐静脉作为冠状动脉旁路移植术治疗多支冠状动脉疾病的第三根血管:十年文献回顾。

Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review.

机构信息

a:1:{s:5:"en_US";s:140:"Department of Cardiac-Thoracic and Vascular Surgery, Unit of Cardiac Surgery, University Hospital Azienda Ospedaliera-Universitaria di Parma";}.

Department of Cardio-Thoracic and Vascular Surgery, Cardiac Surgery Unit, University Hospital "Azienda Ospedaliera-Universitaria" of Parma, University of Parma, Parma, Italy..

出版信息

Acta Biomed. 2022 May 11;93(2):e2022049. doi: 10.23750/abm.v93i2.11370.

Abstract

Coronary artery bypass grafting is the gold standard strategy for obtaining complete coronary revascularization in patients with multivessel coronary artery disease. The recent AHA and EACTS guidelines on myocardial revascularization recommend total arterial revascularization, especially in younger patients, whenever possible. However, the use of saphenous vein grafts in association with single or bilateral internal thoracic artery (SITA, BITA) instead of arterial grafts (radial arteries, right gastroepiploic artery and inferior epigastric artery) is widespread. We analyzed literature from the last ten years (January 2010 to December 2020) looking for evidence in favour of the use of a radial artery compared to a saphenous vein in association with BITA. We identified nine studies (4 Systematic Reviews and Meta-analyses and 6 large cohort observational studies with propensity score-matching) that compared arterial with saphenous grafts as third conduit. The main finding of the review is the higher rate of freedom from any cardiac adverse event in the population which reached Total Arterial myocardial Revascularization (TAR). A probable reason for the limited application of TAR as a strategy is the shortage of Randomized Controlled Trials (RCTs).

摘要

冠状动脉旁路移植术是多支冠状动脉疾病患者获得完全冠状动脉血运重建的金标准策略。最近的美国心脏协会(AHA)和欧洲心胸外科学会(EACTS)心肌血运重建指南建议,只要有可能,应尽可能采用全动脉血运重建,尤其是在年轻患者中。然而,在单支或双侧胸廓内动脉(SITA、BITA)联合使用大隐静脉而非动脉移植物(桡动脉、右胃网膜动脉和腹壁下动脉)的情况仍很普遍。我们分析了过去十年(2010 年 1 月至 2020 年 12 月)的文献,寻找支持桡动脉与 BITA 联合使用优于大隐静脉的证据。我们确定了 9 项研究(4 项系统评价和荟萃分析以及 6 项大型队列观察性研究,采用倾向评分匹配),比较了动脉与大隐静脉作为第三根移植物的效果。综述的主要发现是,在达到全动脉心肌血运重建(TAR)的人群中,任何心脏不良事件的无事件率更高。TAR 作为一种策略的应用有限的一个可能原因是随机对照试验(RCT)的缺乏。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验